The Effect of Individualised Homoeopathic Treatment Using the Grant Bentley Method in Premenstrual Syndrome
Launched by UNIVERSITY OF JOHANNESBURG · Jun 22, 2015
Trial Information
Current as of May 08, 2025
Completed
Keywords
ClinConnect Summary
The study is of an embedded mixed method design using the PMS chart and case studies and will take place over 12 weeks at the University of Johannesburg (UJ) Health Centre. Using purposive sampling, 10 female participants between the ages of 18 to 40 years will be recruited by means of advertisements at the Homoeopathic Health Centre, campus gym and female residences on the Doornfontein campus of the University of Johannesburg, as well as various health shops, practices and gyms in the Auckland Park and Killarney areas, with the relevant permission granted.
Each potential participant will ...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- * Females (aged 18-40) suffering from at least one PMS symptom from both of the following physical and psychological symptoms, for at least 3 consecutive menstrual cycles:
- • Physical symptoms: headache, breast tenderness, abdominal bloating, food cravings and swelling of extremities
- • Psychological symptoms: depression, anxiety, irritability, social withdrawal and memory changes;
- • symptoms that are present from at least day 14 (2 weeks before menstruation) of the menstrual cycle, are relieved by day 4 of menstruation, and do not reoccur until after day 13 of the menstrual cycle; and
- • if currently on the OCP, they must be using the same brand of medication for 3 consecutive months.
- Exclusion Criteria:
- • Females on any kind of chronic medication that may interfere with PMS symptoms such as medication for hyperthyroidism, hypothyroidism, diabetes mellitus and psychiatric disorders;
- • are suffering from dysphoric disorder (a severe form of premenstrual syndrome);
- • are on hormonal treatment (except OCP);
- • have been pre-diagnosed with any anxiety or depression disorders; and/or
- • have irregular menses.
About University Of Johannesburg
The University of Johannesburg (UJ) is a leading higher education institution in South Africa, renowned for its commitment to research and innovation across various disciplines, including health sciences. As a clinical trial sponsor, UJ leverages its academic expertise and state-of-the-art facilities to conduct rigorous and ethically sound clinical research. The university fosters collaboration between researchers, healthcare professionals, and industry partners, aiming to advance medical knowledge and improve patient outcomes. UJ is dedicated to upholding the highest standards of scientific integrity and compliance, contributing to the global body of evidence-based medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Johannesburg, Gauteng, South Africa
Patients applied
Trial Officials
Reshma Patel, M.TechHom
Study Director
University of Johannesburg
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials